Raman, S. R., Man, K. K. C., Bahmanyar, S., Bushnell, G., KaoYang, Y.-H., Karlstad, O., … Wong, I. C. K. (2017). Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries. In Pharmacoepidemiology and Drug Safety (Vol. 26, pp. 333–333). WILEY.

Raman, Sudha R., Kenneth K. C. Man, Shahram Bahmanyar, Greta Bushnell, Yea-Huei KaoYang, Oystein Karlstad, Kiyoshi Kubota, et al. “Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries.” In Pharmacoepidemiology and Drug Safety, 26:333–333. WILEY, 2017.

Raman SR, Man KKC, Bahmanyar S, Bushnell G, KaoYang Y-H, Karlstad O, et al. Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries. In: Pharmacoepidemiology and Drug Safety. WILEY; 2017. p. 333–333.

Raman, Sudha R., et al. “Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries.” Pharmacoepidemiology and Drug Safety, vol. 26, WILEY, 2017, pp. 333–333.

Raman SR, Man KKC, Bahmanyar S, Bushnell G, KaoYang Y-H, Karlstad O, Kubota K, Lai ECC, Martikainen JE, Maura G, Montero D, Pottegard A, Pratt N, Roughead EE, Sturmer T, Su C-C, Zoega H, Sturkenboom MCJM, Wong ICK. Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries. Pharmacoepidemiology and Drug Safety. WILEY; 2017. p. 333–333.